• Users Online: 2779
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
Year : 2018  |  Volume : 30  |  Issue : 3  |  Page : 200-202

Serous macular detachments are not always benign

Department of Ophthalmology, Amala Institute of Medical Sciences, Thrissur, Kerala, India

Date of Web Publication17-Dec-2018

Correspondence Address:
Merie Mathew
Amala Institute of Medical Sciences, Amala Nagar, Thrissur - 680 555, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/kjo.kjo_5_18

Rights and Permissions

The incidence of choroidal metastases from lung adenocarcinoma without a history of primary tumor detection was rarely reported. A 59-year-old male presented with diminution of vision in the left eye 10 days after starting the antitubercular treatment. The vision deteriorated dramatically, and ancillary tests revealed a metastatic lesion in the left eye from adenocarcinoma of the lung. This case report highlights the possibility of intraocular metastases in adults who present with symptoms of blurring of vision of short duration.

Keywords: Adenocarcinoma, intraocular metastases, serous macular detachment

How to cite this article:
Uvaraj T, Mathew M. Serous macular detachments are not always benign. Kerala J Ophthalmol 2018;30:200-2

How to cite this URL:
Uvaraj T, Mathew M. Serous macular detachments are not always benign. Kerala J Ophthalmol [serial online] 2018 [cited 2022 Oct 7];30:200-2. Available from: http://www.kjophthal.com/text.asp?2018/30/3/200/247586

  Introduction Top

Serous macular detachment (SMD) is a separation of neurosensory layer from retinal pigment epithelium (RPE) occurring at the macula. Although the exact mechanism of development is not known, it may occur in retinal or choroidal vascular leakage with RPE dysfunction. It occurs in a variety of benign and malignant conditions including choroidal hemangioma, choroidal granuloma, posterior scleritis, atypical central serous chorioretinopathy, amelanotic melanoma, and choroidal metastases with similar fundoscopic appearance.[1] The unique feature of our case reported is that the primary site of the tumor was not detected or suspected at the time of manifestation in the eye. The incidence of choroidal metastases from metastatic lung cancer was reported to be 2%–6.7%. Within the uvea, 88% of metastases are to the choroid, followed by metastases to the iris (9%), and ciliary body (2%).[2] Hence, this case report is significant for its rarity of presentation.

  Case Report Top

A 59-year-old healthy male was referred from pulmonology department with a history of defective vision of the left eye OS noticed for 3 days, to rule out drug toxicity. The patient was on antituberculous treatment for 10 days after core lung biopsy showing caseating granulomatous lesion in the right lower lobe. Ophthalmic evaluation revealed best-corrected visual acuity (BCVA) 6/9 in the OD and 6/12 in the OS. Color vision and the anterior segment examination were within normal limits in both eyes. OD fundus was normal. In OS, there was no vitritis; disc and vessels were normal with a dull macula. Near visual acuity of OD was N6 and OS was N10. Optical coherence tomography (OCT) macula OS showed a small SMD with foveal thickness of 370 microns; there was no underlying pigment epithelial detachment. Humphrey field analysis showed a central scotoma in the OS. The patient was prescribed anti-inflammatory eye drops and was advised to review after 1 week. After 1 week, his vision was progressively decreasing in the OS (BCVA 6/24). A repeat OCT was taken, and SMD was seen to be tripled with foveal thickness of 1078 microns [Figure 1]a. Detailed reexamination of the fundus showed a small yellowish raised flat lesion superotemporal to the disc with exudative retinal detachment all around involving the macula [Figure 1]b and [Figure 2]. With the suspicion of choroidal metastases/choroidal tubercle, the patient was referred to the higher center for further evaluation. Fundus fluorescein angiography (FFA) was done which showed hyperfluorescence increasing in the late phase with leakage [Figure 3]. Indocyanine green (ICG) angiogram was done which showed a hypofluorescent choroidal lesion with patchy staining of the surface of the lesion. There was no disc leakage or evidence of any inflammation [Figure 4]. All features were in favor of choroidal metastases, and hence, the patient was referred to pulmonologist to have a repeat biopsy from another site of lung lesion. A computed tomography (CT)-guided lung biopsy was taken, and histopathology report was suggestive of a moderately differentiated adenocarcinoma [Figure 5]. The patient was then referred to oncologist for further management.
Figure 1: (a) Optical coherence tomography macula on the second visit and (b) Optical coherence tomography through the lesion

Click here to view
Figure 2: Yellowish raised flat lesion in the superotemporal aspect with exudative retinal detachment

Click here to view
Figure 3: Fundus fluorescein angiography with hyperfluorescence in the late phase

Click here to view
Figure 4: Indocyanine green angiogram showing blockage of background staining and patchy staining of tumor surface

Click here to view
Figure 5: Histopathological examination showing adenocarcinoma of the lung (H and E, ×20)

Click here to view

  Discussion Top

In general, tumors that metastasize to the eye are carcinomas. Lung carcinoma is the second common primary site.[3],[4] Unlike carcinoma breast, lung secondaries are seen earlier. The uveal tract is the common site of metastases and is hematogenous. The most common route is through the pulmonary circulation. A small number of metastases do occur directly to the arterial system through Batson's vertebral plexus bypassing the pulmonary circulation.[5] Tumor emboli travel through carotid artery and reach the eye through ophthalmic artery. There is a predilection for OS due to the direct takeoff of the carotid artery on the left side.[3] After reaching ophthalmic artery, they reach the posterior choroid through posterior ciliary arteries which are numerous.[6] The tumor cells leave the circulation, embedded in highly vascular uveal stroma and proliferate. The common site of choroid involved is between macula and equator.[3] Submacular choroid and temporal fundus are more involved.[5]

Some points to distinguish metastatic carcinoma from primary choroidal melanoma are its site (posterior pole), infiltrative nature, flat or dome-shaped, creamy yellow color, often multifocal may be bilateral with large exudative retinal detachment with shifting fluid, rapid growth, and absence of dual circulation. In ultrasound B scan, choroidal metastases are characterized by a significantly lower height-to-base ratio than melanomas. In ultrasound A scan, a high-internal reflectivity is seen unlike melanoma. FFA, ICG, fine-needle aspiration biopsy, and color flow mapping (hypervascularity, lack of a “dominant vessel,” and typically have a “peripheral pattern” blood flow) also help to distinguish from other choroidal lesions.[2],[7],[8] In ICG angiography, choroidal metastasis shows hypofluorescence at the site of metastasis throughout the phases.[9] In FFA, the metastatic tumor will show early staining with fluorescein leakage into the lesion. Arterial phase of the FFA shows numerous collection areas of dyes in the choroid. Retinal vessels overlie the areas of dye retention.

Choroidal tuberculosis presents as multiple tubercles (0.3–3 mm) or solitary tuberculoma (2–3 disc diameter) at the posterior pole. They are usually yellowish gray or white with serous macular detachments and hemorrhages. Angiographically, tubercles are hypofluorescent initially with progressive hyperfluorescence in late phases. Tuberculoma shows early hyperfluorescence with leakage of dye around the margins in the late phase.[10] There are no typical angiogram findings for choroidal tuberculoma. On ICGA, hypofluorescent choroidal lesions are seen in all phases. Ultrasound B scan shows elevated mass with absence of scleral echo. In A scan, low internal reflectivity and high vascularity may simulate melanoma.[10] CT/X-ray chest and polymerase chain reaction of intraocular fluid are the confirmatory tests.

Patients with solitary intraocular metastases without the involvement of vital organs are surviving longer. Treatments include plaque radiotherapy (solitary metastases), external beam radiation therapy, and photodynamic therapy if detected early.[2],[7],[8] Bevacizumab, a potent monoclonal antibody, has also been employed for the treatment of choroidal metastases and has shown promising results.[2],[4],[7] In advanced cases, chemotherapy, immune therapy, and hormone therapy are recommended.

This case study concluded that a careful eye examination could be an important staging procedure in tumors known to involve the eye or adnexa which may be the initial site of metastases. Intraocular metastases should be considered in adults between fourth and seventh decades of life while evaluating patients with unexplained blurring of vision, uveitis, glaucoma, iris nodules, rubeosis iridis, and large exudative retinal detachment.


The authors would like to acknowledge the valuable help of Dr. Ajith TA, Professor, Department of Biochemistry, Amala Institute of Medical Sciences, Thrissur, Kerala, India, during the preparation of this manuscript.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Salem MB, Chebbi A, Rouatbi A, Korbi M, Zbiba W, Bouguila H. Pitfalls in the diagnosis of choroidal tumors: 3 case reports of choroidal masses. Research 2017;4:2264. DOI//dx.doi.org/10.13070/rs.en.4.2264.  Back to cited text no. 1
Smith A. Choroidal Metastases – EyeWiki. Eyewiki.aao.org; 2018. Available from: http://www.eyewiki.aao.org/Choroidal_Metastases. [Last accessed on 2018 Jan 25].  Back to cited text no. 2
Dobree J, Duke-Elder S. System of Ophthalmology. London: Henry Kimpton; 1967.  Back to cited text no. 3
Giuliari GP, Sadaka A. Uveal metastatic disease: Current and new treatment options (review). Oncol Rep 2012;27:603-7.  Back to cited text no. 4
Jakobiec F, Albert D. Principles and Practice of Ophthalmology. 2nd ed. Philadelphia: W.B. Saunders; 2000.  Back to cited text no. 5
Ryan S, Wilkinson C. Retina. 4th ed. St. Louis, Missouri: Mosby; 2006.  Back to cited text no. 6
Arepalli S, Kaliki S, Shields CL. Choroidal metastases: Origin, features, and therapy. Indian J Ophthalmol 2015;63:122-7.  Back to cited text no. 7
[PUBMED]  [Full text]  
Bowling B. Kanski's Clinical Ophthalmology. 8th ed. Edinburgh: Elsevier; 2016.  Back to cited text no. 8
Pal BP, Garge S, Khetan V. Choroidal melanoma: A short review with an Indian perspective. Oman J Ophthalmol 2017;10:135-44.  Back to cited text no. 9
[PUBMED]  [Full text]  
Yanoff M, Duker JS. Ophthalmology. 4th ed. St. Louis, Missouri: Mosby; 1999.  Back to cited text no. 10


  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article
Case Report
Article Figures

 Article Access Statistics
    PDF Downloaded180    
    Comments [Add]    

Recommend this journal